Literature DB >> 22157274

Fatal acquired hemophilia A in a patient with rheumatoid arthritis treated with adalimumab.

Subha Arthanari1, Hume Ahmad, Mohamed Nisar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22157274     DOI： 10.1097/RHU.0b013e31823ee3cd

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  4 in total

Review 1.  Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence.

Authors:  Sambhawana Bhandari; Maun Ranjan Baral; Matthew Barbery; Alla Rudinskaya; Oleg Sostin
Journal:  Ann Hematol       Date:  2022-06-27       Impact factor: 4.030

2.  Factor XI deficiency diagnosed following use of adalimumab.

Authors:  Guven Cetin; Cumali Karatoprak; Muharrem Kiskac; Mehmet Zorlu; Aylin Rezvani; Mehmet Ali Cikrikcioglu
Journal:  Indian J Pharmacol       Date:  2014 Sep-Oct       Impact factor: 1.200

Review 3.  Targeting Acquired Hemophilia A with Rheumatoid Arthritis by a Rituximab Shot: A Case Report and Review of the Literature.

Authors:  Imad Ghozlani; Aziza Mounach; Mirieme Ghazi; Anass Kherrab; Radouane Niamane
Journal:  Am J Case Rep       Date:  2018-05-21

4.  Acquired Hemophilia Associated with Rheumatic Diseases: A Case-Based Systematic Review.

Authors:  Qi Tang; Jiafen Liao; Xi Xie
Journal:  J Inflamm Res       Date:  2022-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.